Clinical features of cohort patients
| Factor . | n/N . | % . | Median . | Range . |
|---|---|---|---|---|
| Age at diagnosis, y | 61 | 43-78 | ||
| No. of lines of therapy before sampling | 3 | 1-9 | ||
| Time from diagnosis to sampling, mo | 52.3 | 3-165 | ||
| Follow-up after sampling, mo | 14.6 | |||
| Best response after sampling | ||||
| VGPR | 5/41 | 12.2 | ||
| PR | 14/41 | 34.2 | ||
| MR | 6/41 | 14.6 | ||
| SD | 7/41 | 17.1 | ||
| PD | 8/41 | 19.5 | ||
| Lost to follow-up | 1/41 | 2.4 | ||
| Relapse | 40/41 | 97.6 | ||
| Death | 37/41 | 90.2 | ||
| Cause of death | ||||
| Progressive disease | 34/37 | 91.9 | ||
| Treatment related mortality | 2/37 | 5.4 |
| Factor . | n/N . | % . | Median . | Range . |
|---|---|---|---|---|
| Age at diagnosis, y | 61 | 43-78 | ||
| No. of lines of therapy before sampling | 3 | 1-9 | ||
| Time from diagnosis to sampling, mo | 52.3 | 3-165 | ||
| Follow-up after sampling, mo | 14.6 | |||
| Best response after sampling | ||||
| VGPR | 5/41 | 12.2 | ||
| PR | 14/41 | 34.2 | ||
| MR | 6/41 | 14.6 | ||
| SD | 7/41 | 17.1 | ||
| PD | 8/41 | 19.5 | ||
| Lost to follow-up | 1/41 | 2.4 | ||
| Relapse | 40/41 | 97.6 | ||
| Death | 37/41 | 90.2 | ||
| Cause of death | ||||
| Progressive disease | 34/37 | 91.9 | ||
| Treatment related mortality | 2/37 | 5.4 |
MR, minor response; PD, progressive disease; PR, partial response; SD, stable disease; VGPR, very good partial response.